Endocrine pathways

GHRH, GHRP, and related endocrine-pathway references

Products
Sermorelin / Ipamorelin, Tesamorelin
Price per vial
From $54.99
Status
Launching end of 2026. Lot documentation pending.

Overview

The endocrine system releases hormones into the bloodstream to regulate growth, reproduction, metabolism, and stress. The growth hormone axis runs from hypothalamic GHRH to pituitary GH, then to liver IGF-1 and its target tissues. Gonadotropins such as LH and FSH regulate reproductive function through testicular and ovarian targets.

Research focus

Endocrine pathway research studies how GH secretion is controlled along the GHRH, ghrelin receptor and IGF-1 axis, and compares synthetic secretagogues with endogenous signals in cell and animal models.

Catalogue products

Tesamorelin and the Sermorelin / Ipamorelin blend are the catalogue compounds associated with growth hormone axis research. Published findings depend on the study design and do not establish a general conclusion.

For research and development use only. Not for human or veterinary use or consumption.

  • Sermorelin / Ipamorelin

    Sermorelin and Ipamorelin blend

    Coming soon

  • Tesamorelin

    GHRH analog

    5 mg · 10 mgFrom $54.99

    Tesamorelin is a stabilised analogue of growth-hormone-releasing hormone studied in growth-hormone-axis research models for GHRH receptor activation and downstream IGF-1 signalling.

References

Research publications describe the materials and methods used in those studies. They do not verify the contents of an individual Radian vial.